DOLBY LABORATORIES, INC. (DLB) FY2026 Q3 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-26

Swipe to see the full flow
DOLBY LABORATORIES, INC. (DLB) FY2026 Q3 Balance SheetBalance sheet as of 2026-06-26. The chart shows assets, liabilities and equity at that date.Current liabilities$416.33 MLiabilities$563.89 MCurrent assets$1.33 BAssets$3.16 BNon-current liabilities$147.56 MEquity$2.59 BGross equity(calculated)$2.61 BNon-current assets$1.83 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsAccounts receivable, net of allowance for credit losses of $9,593 and $7,221Contract assets, net of allowance for credit losses of $94 and $101Restricted cashPrepaid expenses and other current assetsInventories, netShort-term investmentsGoodwillProperty, plant, and equipment, netIntangible assets, netDeferred taxesOther non-current assetsLong-term investmentsOperating lease right-of-use assetsAccrued liabilitiesContract liabilitiesAccounts payableOperating lease liabilitiesOther non-current liabilitiesNon-current operating lease liabilitiesNon-current contract liabilitiesRetained earningsCommon stock - Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 59,393,554 shares issued and outstanding as of June 26, 2026 and 60,802,616 as of September 26, 2025Common stock - Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 34,251,901 shares issued and outstanding as of June 26, 2026 and 34,660,045 as of September 26, 2025Noncontrolling interestCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated other comprehensive lossAccrued liabilitiesAccrued liabilities$360.41 MCurrent liabilitiesCurrent liabilities$416.33 MContract liabilitiesContract liabilities$33.59 MCash and cash equivalentsCash and cash equivalents$669.39 MLiabilitiesLiabilities$563.89 MCurrent assetsCurrent assets$1.33 BAccounts payableAccounts payable$12.47 MAccounts receivable, net of allowance for credit losses of $9,593 and $7,221Receivables, net$285.15 MOperating lease liabilitiesOperating lease liabilities$9.86 MContract assets, net of allowance for credit losses of $94 and $101Contract assets, net$206.88 MAssetsAssets$3.16 BOther non-current liabilitiesOther non-current liabilities$86.50 MNon-current liabilitiesNon-current liabilities$147.56 MRestricted cashRestricted cash$69.49 MNon-current operating lease liabilitiesNon-current operating lease liabilities$37.59 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$63.71 MNon-current contract liabilitiesNon-current contract liabilities$23.46 MEquityEquity$2.59 BInventories, netInventories, net$30.77 MShort-term investmentsShort-term investments$652.00 KGross equity (calculated)Gross equity(calculated)$2.61 BGoodwillGoodwill$528.34 MNon-current assetsNon-current assets$1.83 BRetained earningsRetained earnings$2.60 BProperty, plant, and equipment, netProperty, plant, and equipment, net$459.12 MIntangible assets, netIntangible assets, net$382.43 MDeferred taxesDeferred taxes$213.17 MCommon stock - Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 59,393,554 shares issued and outstanding as of June 26, 2026 and 60,802,616 as of September 26, 2025Common stock - Class A, $0.001par value, one vote per share$52.00 KOther non-current assetsOther non-current assets$118.66 MLong-term investmentsLong-term investments$86.44 MCommon stock - Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 34,251,901 shares issued and outstanding as of June 26, 2026 and 34,660,045 as of September 26, 2025Common stock - Class B, $0.001par value, ten votes per share$40.00 KOperating lease right-of-use assetsOperating lease right-of-use assets$42.40 MNoncontrolling interestNoncontrolling interest$9.17 MAccumulated other comprehensive lossAccumulated other comprehensive loss−$15.47 M
Chart details

DOLBY LABORATORIES, INC. (DLB) FY2026 Q3 Balance Sheet

Balance sheet as of 2026-06-26. The chart shows assets, liabilities and equity at that date.

Assets
3,156,602,000 US dollars
Current assets
1,326,041,000 US dollars
Non-current assets
1,830,561,000 US dollars
Liabilities
563,887,000 US dollars
Current liabilities
416,329,000 US dollars
Non-current liabilities
147,558,000 US dollars
Equity
2,592,715,000 US dollars
Noncontrolling interest
9,168,000 US dollars. Included in consolidated equity; this amount is not added again.
Cash and cash equivalents
669,394,000 US dollars
Accounts receivable, net of allowance for credit losses of $9,593 and $7,221
285,148,000 US dollars
Contract assets, net of allowance for credit losses of $94 and $101
206,881,000 US dollars
Restricted cash
69,492,000 US dollars
Prepaid expenses and other current assets
63,706,000 US dollars
Inventories, net
30,768,000 US dollars
Short-term investments
652,000 US dollars
Goodwill
528,343,000 US dollars
Property, plant, and equipment, net
459,115,000 US dollars
Intangible assets, net
382,434,000 US dollars
Deferred taxes
213,171,000 US dollars
Other non-current assets
118,660,000 US dollars
Long-term investments
86,437,000 US dollars
Operating lease right-of-use assets
42,401,000 US dollars
Accrued liabilities
360,407,000 US dollars
Contract liabilities
33,593,000 US dollars
Accounts payable
12,470,000 US dollars
Operating lease liabilities
9,859,000 US dollars
Income taxes payable
0 US dollars
Other non-current liabilities
86,504,000 US dollars
Non-current operating lease liabilities
37,591,000 US dollars
Non-current contract liabilities
23,463,000 US dollars
Retained earnings
2,598,923,000 US dollars
Common stock - Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 59,393,554 shares issued and outstanding as of June 26, 2026 and 60,802,616 as of September 26, 2025
52,000 US dollars
Common stock - Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 34,251,901 shares issued and outstanding as of June 26, 2026 and 34,660,045 as of September 26, 2025
40,000 US dollars
Noncontrolling interest
9,168,000 US dollars
Accumulated other comprehensive loss
negative 15,468,000 US dollars
Gross equity (calculated)
2,608,183,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
DOLBY LABORATORIES, INC. (DLB) FY2026 Q3 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!